PATENT CLAIM ANALYSIS

Application Number: 15951005
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "260100"]

Abstract:
The present disclosure relates to a method of preventing and/or treating liver disease comprising administering an ASK1 inhibitor in combination with a ACC inhibitor and an FXR agonist to a patient in need thereof.

Claim (Index 14):
The method of  claim 2 , wherein the ASK1 inhibitor is a compound of Formula (VII), the ACC inhibitor is a compound of Formula (IV), and the FXR agonist is a compound of Formula (VI).

Metadata:
- Claim Count in Document: 65.0
- Percentile: 91.0
- Lexical Diversity: 1.2069
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15508968', '16335662', '15481365', '14757585', '15612124']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7820724807730979
- 35 USC 102 Novelty (BERT): 0.5387597661255465
- Combined Prediction Score: 0.7577412093083428
- Mean Citation Score: 287.104688
- Max Citation Score: 380.1886
- Similarity Product: 238.6458235746145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test